Genetic etiology of Fronto-Temporal Dementia
额颞叶痴呆的遗传病因学
基本信息
- 批准号:7964097
- 负责人:
- 金额:$ 11.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:9p21AllelesAmyotrophic Lateral SclerosisAtrophicAutopsyBrainCandidate Disease GeneChromosomesClinicalCytoplasmic InclusionDataDementiaDiagnosisDiseaseEpidemiologyEtiologyGenesGeneticGenetic Predisposition to DiseaseGenotypeHaplotypesImpaired cognitionIndividualLaboratoriesLinkLinkage Disequilibrium MappingLondonMessenger RNAMotor ManifestationsMotor NeuronsMutationNetherlandsNeuronsPGRN genePathogenesisPatientsPhenotypeProgranulinProteinsPsychiatryResearch SubjectsRiskRoleScreening procedureSpinal CordStagingTemporal LobeTissue ExtractsUbiquitinVariantWorkbasecohortfrontal lobegenetic risk factorgenetic variantmotor neuron degenerationneurogeneticsprotein TDP-43
项目摘要
During the last fiscal year, we have completed two projects that are directly relevant to FTD. First, the progranulin (PGRN) gene was sequenced in 134 Italian sporadic patients and 12 familial cases. Mutations in this gene has been previously identified as a cause of ubiquitin-positive FTD, but the role of this gene in the causation of ALS and ALS-FTD is unclear. Mutational screening revealed a heterozygous change (p.S120Y) in a patient diagnosed with sporadic ALS-FTD. This change was identical to one that we had previously identified in another ALS-FTD patient (cf Schymick et al., J Neurol Neurosurg Psychiatry. 2007; 78:754-6). Haplotype analysis showed a conserved PGRN region among these two subjects consistent with common ancestor allele. This finding confirms that the missence mutation p.S120Y variant causes degeneration of frontal and temporal lobe neurons, as well as motor neurons (i.e. ALS-FTD) in rare cases.
In the second project, a large scale two-stage linkage disequilibrium mapping approach was undertaken of the chromosome 9p21 region which has been previously linked to FTD, ALS and ALS-FTD phenotypes. An association of ubiquitin associated protein 1 (UBAP1; OR 1.42 95% CI 1.08-1.88, P=0.013) was identified and then replicated in an additional two independent cohorts from the Netherlands (OR 1.33 95% CI 1.04-1.69, P=0.022), the USA (OR 1.4 95% CI 1.02-1.92, P=0.032), but not in a Spanish cohort (OR 1.45 95% CI 0.97-2.17, P=0.064) or in a cohort from London (OR 0.99 95% CI 0.72-1.37, P=0.989). Quantitative analysis of UBAP1 mRNA extracted from tissue from the Manchester cases demonstrated a significant reduction of expression from the disease-associated haplotype. In addition, a case of familial FTD was identified that demonstrated colocalisation of UBAP1 and TDP-43 in the neuronal cytoplasmic inclusions in the brain of this individual. This data identified UBAP1 as a potential genetic risk factor for FTD.
In summary, the current year has been successful in identifying genetic variants important in the pathogenesis of FTD using candidate gene approaches. Each of the two studies employed large cohorts of research subjects, and utilized the sequencing and genotyping facilities available within the Laboratory of Neurogenetics, NIA.
在上一个财政年度,我们完成了两个与FTD直接相关的项目。首先,在134例意大利零星患者和12例家族病例中对幼体蛋白(PGRN)基因进行了测序。该基因中的突变先前已被鉴定为泛素阳性FTD的原因,但是该基因在ALS和ALS-FTD因果关系中的作用尚不清楚。突变筛查显示在诊断为零星ALS-FTD的患者中发生了杂合的变化(P.S120Y)。这种变化与我们以前在另一位ALS-FTD患者中发现的变化相同(CF Schymick等,J Neurol Neurol NeurosurgPsychiatry。2007; 78:754-6)。单倍型分析表明,这两个与共同祖先等位基因一致的受试者中有一个保守的PGRN区域。这一发现证实,在极少数情况下,P.S120y的失误突变会导致额叶和颞叶神经元以及运动神经元(即ALS-FTD)的变性。
在第二个项目中,大规模的两阶段连锁不平衡映射方法是对9p21染色体区域进行的,该区域先前已与FTD,ALS和ALS-FTD表型相关。鉴定了泛素相关蛋白1(UBAP1;或1.42 95%CI 1.08-1.88,p = 0.013)的关联,然后在荷兰的另外两个独立队列中复制,然后在荷兰(OR 1.33 95%CI 1.04-1.69,p = 0.022),p = 0.022),p = 0.022),USA(OS 1.4 95%CI 1.02),OS 1.4 95%。不在西班牙队列中(或1.45 95%CI 0.97-2.17,p = 0.064)或伦敦的同伴(或0.99 95%CI 0.72-1.37,p = 0.989)。从曼彻斯特案例中提取的UBAP1 mRNA的定量分析表明,与疾病相关的单倍型的表达显着降低。此外,还确定了一个家族性FTD的一个情况,该病例证明了该个体大脑中神经元细胞质内包含中UBAP1和TDP-43的共定位。该数据将UBAP1确定为FTD的潜在遗传危险因素。
总而言之,本年度在使用候选基因方法中识别在FTD发病机理中重要的遗传变异方面已经成功。两项研究中的每一项都采用了大量研究对象,并利用了NIA神经遗传学实验室内可用的测序和基因分型设施。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bryan Traynor其他文献
Bryan Traynor的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bryan Traynor', 18)}}的其他基金
Genetic etiology of Amyotrophic Lateral Sclerosis
肌萎缩侧索硬化症的遗传病因学
- 批准号:
10913163 - 财政年份:
- 资助金额:
$ 11.36万 - 项目类别:
Genome sequencing of Lewy Body Dementia and Frontotemporal Dementia: a public resource for the study of Alzheimer's disease and related dementias
路易体痴呆和额颞叶痴呆的基因组测序:研究阿尔茨海默病和相关痴呆的公共资源
- 批准号:
10913165 - 财政年份:
- 资助金额:
$ 11.36万 - 项目类别:
Genome sequencing of Lewy Body Dementia and Frontotemporal Dementia: a public resource for the study of Alzheimers disease and related dementias
路易体痴呆和额颞叶痴呆的基因组测序:阿尔茨海默病和相关痴呆研究的公共资源
- 批准号:
10005769 - 财政年份:
- 资助金额:
$ 11.36万 - 项目类别:
Genetic etiology of Amyotrophic Lateral Sclerosis
肌萎缩侧索硬化症的遗传病因学
- 批准号:
10005767 - 财政年份:
- 资助金额:
$ 11.36万 - 项目类别:
相似国自然基金
等位基因聚合网络模型的构建及其在叶片茸毛发育中的应用
- 批准号:32370714
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于等位基因非平衡表达的鹅掌楸属生长量杂种优势机理研究
- 批准号:32371910
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
基于人诱导多能干细胞技术研究突变等位基因特异性敲除治疗1型和2型长QT综合征
- 批准号:82300353
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACR11A不同等位基因调控番茄低温胁迫的机理解析
- 批准号:32302535
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠杆菌多粘菌素异质性耐药中phoPQ等位基因差异介导不同亚群共存的机制研究
- 批准号:82302575
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
SPOP modifies neurodegenerative proteinopathy in Alzheimer’s Disease.
SPOP 可以改善阿尔茨海默病中的神经退行性蛋白病。
- 批准号:
10675938 - 财政年份:2023
- 资助金额:
$ 11.36万 - 项目类别:
Comprehensive Harmonization and Analysis of Case/Control Whole Genome Sequencing Data from the ALS/FTD Compute Project
来自 ALS/FTD 计算项目的病例/对照全基因组测序数据的全面协调和分析
- 批准号:
10592917 - 财政年份:2023
- 资助金额:
$ 11.36万 - 项目类别:
Optimization of CRISPR genome editor and its delivery strategy for C9orf72 frontotemporal dementia
C9orf72额颞叶痴呆的CRISPR基因组编辑器优化及其递送策略
- 批准号:
10746565 - 财政年份:2023
- 资助金额:
$ 11.36万 - 项目类别:
Correction of Neurological Disease via Allele Specific Excision of Pathogenic Repeats
通过等位基因特异性切除致病重复序列来纠正神经系统疾病
- 批准号:
10668665 - 财政年份:2023
- 资助金额:
$ 11.36万 - 项目类别:
Advanced Delivery Platforms for Base Editing In Vivo
用于体内碱基编辑的先进交付平台
- 批准号:
10682172 - 财政年份:2023
- 资助金额:
$ 11.36万 - 项目类别: